Respiration Physiology 114 (1998) 153 – 160
Effect of Fenoterol on PAF-induced lung edema in isolated and
perfused rabbit lungs
Liuska Pesce, Sandra Tristano, Eliot Friedman, Alejandro Comellas,
He ´ctor Marcano, Roberto Sanchez de Leo ´n*
Unidad de Fisiologia Respiratoria, Instituto de Medicina Experimental, Facultad de Medicina, Escuela Luis Razetti,
Uniersidad Central de Venezuela, Caracas, Venezuela
Accepted 24 August 1998
Abstract
We have studied the effects of fenoterol on PAF-induced response in pulmonary circulation. We used 28 isolated
and perfused rabbit lungs preparations: eight control preparations (CP), four vehicles preparations (VP), eight PAF
preparations (PP) with two doses of PAF, one called low dose (LD =0.5 g/kg of weight) and the other high dose
(HD =1 g/kg of weight) and eight Fenoterol preparations (FP) which we administered 0.05 mg of Fenoterol for 15
min, followed by a LD and HD of PAF. FP prevented elevation of pulmonary artery pressure (Ppa) as compared to
PP, at LD of PAF: 12.615 (CI 95%: 8.57–20.885) versus 83.705 (CI 95%: 50.55–114.3) cm of water; and at HD of
PAF: 19.38 (CI 95%: 11.235–28.94) versus 205.1 (CI 95%: 141.3–271) cm of water respectively. FP prevented the
increase in fluid filtration rate (FFR) observed in PP at both doses of PAF LD: 0.765 (CI 95%: 0.07–3.385) versus
-0.01 (CI 95%: -0.05–0.005) g/min; HD: 5.515 (CI 95%: 2.425–8.865) versus 0.03 (CI 95%: 0–0.33) g/min. Our
results suggest that PAF has a vasoconstrictor effect that produces lung edema and this effect is inhibited by
fenoterol. © 1998 Published by Elsevier Science B.V. All rights reserved.
Keywords: Disease; Acute Respiratory Distress Syndrome; Lung edema; Hypertension; Pulmonary; Mammals;
Rabbit; Mediators; Platelet activating factor; Pharmacological agents; Pulmonary blood flow; Fenoterol
1. Introduction
Platelet Activating Factor (PAF) has been
defined as a group of choline-containing phospho-
lipids that stimulate platelets (Mc Manus et al.,
1993). PAF is synthesized by the majority of
inflammatory cells and by the endothelium, being
* Corresponding author. Present address: POBA Interna-
tional 281, PO Box 025255, Miami, FL 33102, USA. Tel.:
+1-582-5086302; fax: +1-582-7316856; e-mail:
rsanchez@ven.net www.rsdl.com.
0034-5687/98/$ - see front matter © 1998 Published by Elsevier Science B.V. All rights reserved.
PII:S0034-5687(98)00082-6